Uzma Haque

1.9k total citations
29 papers, 1.5k citations indexed

About

Uzma Haque is a scholar working on Rheumatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Uzma Haque has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 7 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Uzma Haque's work include Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Uzma Haque is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Uzma Haque collaborates with scholars based in United States, Canada and Belgium. Uzma Haque's co-authors include Susan J. Bartlett, Luis F. Buenaver, Michael T. Smith, Patrick H. Finan, Jennifer A. Haythornthwaite, S. Bounds, Shahid Hussain, Robert R. Edwards, Claudia M. Campbell and Clifton O. Bingham and has published in prestigious journals such as Brain Research, Science Translational Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Uzma Haque

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uzma Haque United States 15 469 326 259 245 218 29 1.5k
Kristine Phillips United States 22 507 1.1× 83 0.3× 386 1.5× 329 1.3× 364 1.7× 34 1.7k
Liana Euller‐Ziegler France 24 654 1.4× 233 0.7× 144 0.6× 188 0.8× 93 0.4× 58 1.8k
Aki Hietaharju Finland 23 849 1.8× 107 0.3× 78 0.3× 372 1.5× 325 1.5× 47 1.9k
Frederick T. Murphy United States 20 983 2.1× 108 0.3× 199 0.8× 430 1.8× 246 1.1× 30 1.8k
S Bombardieri Italy 19 741 1.6× 72 0.2× 210 0.8× 311 1.3× 188 0.9× 33 1.8k
Silje Watterdal Syversen Norway 17 715 1.5× 89 0.3× 133 0.5× 222 0.9× 78 0.4× 39 1.2k
M. Gaubitz Germany 23 730 1.6× 61 0.2× 334 1.3× 355 1.4× 266 1.2× 72 1.7k
Leena Paimela Finland 27 1.5k 3.3× 167 0.5× 302 1.2× 278 1.1× 236 1.1× 63 2.6k
J. W. J. Bijlsma Netherlands 27 1.7k 3.6× 159 0.5× 461 1.8× 263 1.1× 194 0.9× 57 2.6k
Louisa Ho Canada 22 277 0.6× 167 0.5× 65 0.3× 111 0.5× 301 1.4× 52 1.7k

Countries citing papers authored by Uzma Haque

Since Specialization
Citations

This map shows the geographic impact of Uzma Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uzma Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uzma Haque more than expected).

Fields of papers citing papers by Uzma Haque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uzma Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uzma Haque. The network helps show where Uzma Haque may publish in the future.

Co-authorship network of co-authors of Uzma Haque

This figure shows the co-authorship network connecting the top 25 collaborators of Uzma Haque. A scholar is included among the top collaborators of Uzma Haque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uzma Haque. Uzma Haque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grader‐Beck, Thomas, Uzma Haque, John B. Miller, et al.. (2024). Characteristics associated with patient-reported treatment success in psoriatic arthritis. Lara D. Veeken. 64(3). 1111–1121. 2 indexed citations
2.
Bartlett, Susan J., Kathleen M. Andersen, Vivian P. Bykerk, et al.. (2020). Identifying Minimal and Meaningful Change in a Patient‐Reported Outcomes Measurement Information System for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives. Arthritis Care & Research. 74(4). 588–597. 26 indexed citations
3.
Haque, Uzma, et al.. (2020). Anti-Smith Antibody Positivity Without Lupus in the Setting of Lung Cancer. Cureus. 12(5). e8298–e8298. 1 indexed citations
4.
Wu, Michael, et al.. (2019). Clinical Characteristics of Hydralazine-induced Lupus. Cureus. 11(6). e4996–e4996. 8 indexed citations
5.
Haque, Uzma, et al.. (2018). Fevers in Adult Lupus Patients. Cureus. 10(1). e2098–e2098. 8 indexed citations
6.
Fine, Derek M., et al.. (2018). Pauci-immune Glomerulonephritis in Systemic Lupus Erythematosus (SLE). Cureus. 10(7). e2949–e2949. 1 indexed citations
7.
Myint, Zin, Eric J. Dein, Stephen C. Mathai, et al.. (2018). Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension. Cureus. 10(1). e2121–e2121. 3 indexed citations
8.
Richardson, Carrie & Uzma Haque. (2018). Pulmonary Capillaritis in a Patient With Antisynthetase Syndrome and Anti–PL-7 Antibodies. JCR Journal of Clinical Rheumatology. 25(6). e91–e92. 3 indexed citations
9.
Naidoo, Jarushka, Laura C. Cappelli, Patrick M. Forde, et al.. (2017). Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade. The Oncologist. 22(6). 627–630. 53 indexed citations
10.
Cappelli, Laura C., Alan N. Baer, Jemima Albayda, et al.. (2016). Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab. Annals of the Rheumatic Diseases. 76(1). 43–50. 277 indexed citations
11.
Handy, Catherine E., et al.. (2014). T cell ALL presenting as seropositive rheumatoid arthritis: case report and review of the literature on seropositive paraneoplastic arthritis. Clinical Rheumatology. 34(9). 1647–1650. 7 indexed citations
12.
Fert‐Bober, Justyna, Peter A. Nigrović, Erika Darrah, et al.. (2013). Immune-Mediated Pore-Forming Pathways Induce Cellular Hypercitrullination and Generate Citrullinated Autoantigens in Rheumatoid Arthritis. Science Translational Medicine. 5(209). 209ra150–209ra150. 194 indexed citations
13.
Finan, Patrick H., Luis F. Buenaver, S. Bounds, et al.. (2012). Discordance between pain and radiographic severity in knee osteoarthritis: Findings from quantitative sensory testing of central sensitization. Arthritis & Rheumatism. 65(2). 363–372. 354 indexed citations
14.
Park, Jin Kyun, et al.. (2012). Recurrent Kawasaki Disease With Strawberry Tongue and Skin Desquamation in a Young Adult. JCR Journal of Clinical Rheumatology. 18(2). 96–98. 4 indexed citations
15.
Haque, Uzma, Joan M. Bathon, & Jon T. Giles. (2012). Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis. Arthritis Care & Research. 64(10). 1497–1504. 33 indexed citations
16.
Akhter, Ehtisham, et al.. (2011). Prevalence of arthritis in India and Pakistan: a review. Rheumatology International. 31(7). 849–855. 42 indexed citations
17.
Haque, Uzma & Susan J. Bartlett. (2010). Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis.. Clinical and Experimental Rheumatology. 28(5). 745–747. 82 indexed citations
18.
Golding, Amit, Uzma Haque, & Jon T. Giles. (2007). Rheumatoid Arthritis and Reproduction. Rheumatic Disease Clinics of North America. 33(2). 319–343. 36 indexed citations
19.
Haque, Uzma & Joan M. Bathon. (2004). The role of biologicals in early rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 19(1). 179–189. 3 indexed citations
20.
Bright, Gary R., et al.. (1996). Heterogeneity in cytosolic calcium responses to hypoxia in carotid body cells. Brain Research. 706(2). 297–302. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristine Phillips Breakdown of academic impact, for papers by Liana Euller‐Ziegler Breakdown of academic impact, for papers by Aki Hietaharju Breakdown of academic impact, for papers by Frederick T. Murphy Breakdown of academic impact, for papers by S Bombardieri Breakdown of academic impact, for papers by Silje Watterdal Syversen Breakdown of academic impact, for papers by M. Gaubitz Breakdown of academic impact, for papers by Leena Paimela Breakdown of academic impact, for papers by J. W. J. Bijlsma Breakdown of academic impact, for papers by Louisa Ho
Rankless by CCL
2026